Abstract
We had reported that activation of presynaptic histamine H3-receptors inhibits norepinephrine exocytosis from depolarized cardiac sympathetic nerve endings, an action associated with a marked decrease in intraneuronal Ca2+ that we ascribed to a decreased Ca2+ influx. An H3-receptor-mediated inhibition of cAMP-dependent phosphorylation of Ca2+ channels could cause a sequential attenuation of Ca2+ influx, intraneuronal Ca2+ and norepinephrine exocytosis. We tested this hypothesis in sympathetic nerve endings (cardiac synaptosomes) expressing native H3-receptors and in human neuroblastoma SH-SY5Y cells transfected with H3-receptors. Norepinephrine exocytosis was elicited by K+ or by stimulation of adenylyl cyclase with forskolin. H3-receptor activation markedly attenuated the K+- and forskolin-induced norepinephrine exocytosis; pretreatment with pertussis toxin prevented this effect. Similar to forskolin, 8-bromo-cAMP elicited norepinephrine exocytosis but, unlike forskolin, it was unaffected by H3-receptor activation, demonstrating that inhibition of adenylyl cyclase is a pivotal step in the H3-receptor transductional cascade. Indeed, we found that H3-receptor activation attenuated norepinephrine exocytosis concomitantly with a decrease in intracellular cAMP and PKA activity in SH-SY5Y-H3 cells. Moreover, pharmacological PKA inhibition acted synergistically with H3-receptor activation to reduce K+-induced peak intracellular Ca2+ in SH-SY5Y-H3 cells and norepinephrine exocytosis in cardiac synaptosomes. Furthermore, H3-receptor activation synergized with N- and L-type Ca2+ channel blockers to reduce norepinephrine exocytosis in cardiac synaptosomes. Our findings suggest that the H3-receptor-mediated inhibition of norepinephrine exocytosis from cardiac sympathetic nerves results sequentially from H3-receptor-Gi/Go coupling, inhibition of adenylyl cyclase activity, and decreased cAMP formation, leading to diminished PKA activity, and thus, decreased Ca2+ influx through voltage-operated Ca2+ channels.
Footnotes
-
This work was supported by National Institutes of Health Grants HL34125, HL46403, and DK60726 and Minority Access to Research Careers Grant F31GM64875.
-
doi:10.1124/jpet.104.072504.
-
ABBREVIATIONS: H3R, histamine H3-receptor; NE, norepinephrine; [Ca2+]i, intracellular Ca2+ concentration; ω-CTX, ω-conotoxin GVIA; VOCC, voltage-operated Ca2+ channel; HBS, HEPES-buffered saline; PTX, pertussis toxin; PKA, cAMP-dependent protein kinase; CBP, clobenpropit; PVDF, polyvinylidene difluoride; TBS, Tris-buffered saline; DMI, desipramine; CPA, N6-cyclopentyl adenosine; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; ANOVA, analysis of variance; PKI(14-22), PKA inhibitor.
- Received June 8, 2004.
- Accepted August 11, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|